Related Experiment Videos

Early liver transplantation for primary hyperoxaluria type 1 in an infant with chronic renal failure

G Schürmann1, K Schärer, A M Wingen

  • 1Department of Surgery, University of Heidelberg, West Germany.

Insights

Infantile oxalosis, a severe metabolic disorder, can be treated with liver transplantation to address alanine: glyoxylate aminotransferase deficiency. This procedure offers a potential cure for the fatal disease, though its impact on advanced kidney damage requires further study.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatric Medicine

Background:

  • Primary hyperoxaluria type 1 is a severe inherited metabolic disorder.
  • It results from a deficiency in the hepatic enzyme alanine: glyoxylate aminotransferase (AGT).
  • This deficiency leads to excessive oxalate production and deposition, causing renal insufficiency.

Observation:

  • A 22-month-old girl presented with severe type 1 primary hyperoxaluria and chronic renal failure.
  • She underwent a successful liver transplantation to correct the AGT deficiency.

Findings:

  • Endogenous creatinine clearance remained stable at approximately 10 ml/min per 1.73 m2, 23 months post-transplantation.
  • The liver transplant effectively addressed the underlying metabolic defect.

Implications:

  • Liver transplantation presents a potential cure for the otherwise fatal infantile oxalosis.
  • The long-term effect of liver transplantation on kidney function in patients with advanced renal disease remains to be determined.

Related Concept Videos